Cataracts: We have perfected the surgery, but is it time for prevention?

Current Opinion in Ophthalmology

Volumn 22, Issue 1, 2011, Pages 2-3

  Fernandez, Mark M ^a   Afshari, Natalie A ^a  

^a DUKE UNIVERSITY EYE CENTER   (United States)

Author keywords

Antioxidants; Cataract; Disability; Nutrition; Prevention

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; XANTHOPHYLL; ZEAXANTHIN;

CATARACT; DISEASE COURSE; HUMAN; NUTRITION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT; VITAMIN SUPPLEMENTATION;

BLINDNESS; CATARACT; CATARACT EXTRACTION; COST OF ILLNESS; HEALTH EDUCATION; HEALTH PROMOTION; HUMANS;

EID: 79955017177     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e3283416742     Document Type: Review

References (8)

1. Ono K, Hiratsuka Y, Murakami A. Global inequality in eye health: country-level analysis from the Global Burden of Disease Study. Am J Public Health 2010;100:1784-1788. This article presents a detailed review of the socioeconomic impact of various eye diseases in the developed and developing worlds.
2. Glied S, Little SE. The uninsured and the benefits of medical progress. Health Aff (Millwood) 2003;22:210-219. (Pubitemid 41399266)
3. Sach TH, Foss AJ, Gregson RM, et al. Falls and health status in elderly women following first eye cataract surgery: an economic evaluation conducted alongside a randomised controlled trial. Br J Ophthalmol 2007;91:1675-1679. (Pubitemid 350207398)
4. Robman L, Taylor H. External factors in the development of cataract. Eye (Lond) 2005;19:1074-1082. (Pubitemid 41823766)
5. Truscott RJ. Age-related nuclear cataract-oxidation is the key. Exp Eye Res 2005;80:709-725.
6. Glynn RJ, Rosner B, Christen WG. Evaluation of risk factors for cataract types in a competing risks framework. Ophthalmic Epidemiol 2009;16:98-106.
7. Fernandez MM, Afshari NA. Nutrition and the prevention of cataracts. Curr Opin Ophthalmol 2008;19:66-70. (Pubitemid 350307564)
8. Babizhayev MA, Micans P, Guiotto A, Kasus-Jacobi A. N-acetylcarnosine lubricant eyedrops possess all-in-one universal antioxidant protective effects of L-carnosine in aqueous and lipid membrane environments, aldehyde scavenging, and transglycation activities inherent to cataracts: a clinical study of the new vision-saving drug N-acetylcarnosine eyedrop therapy in a database population of over 50 500 patients. Am J Ther 2009;16:517-533.